Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female
- 1Retina Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
- 2Oculoplastic and Orbit Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
- 3Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia
- 4Research Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
- Dr Imtiaz A Chaudhry, Oculoplastic and Orbit Division, King Khaled Eye Specialist Hospital, PO Box 7191, Riyadh 11462, Saudi Arabia; orbitdr{at}hotmail.com
- Accepted 3 February 2007
After diabetic retinopathy, retinal venous occlusion (RVO) is the most common cause of retinopathy leading to severe visual loss in all age groups. Generally, RVO is associated with systemic diseases with significant morbidity and mortality. The risk of RVO is increased in patients older than 65 years of age with systemic hypertension, cardiovascular disease, diabetes and obesity.1 Patients younger than 50 years of age may have other underlying conditions requiring appropriate investigation and treatment.2 3 We describe the development of central retinal venous occlusion (CRVO) and the efficacy of intravitreal triamcinolone acetonide injection (IVTA) for associated cystoid macular oedema (CME) in a young healthy woman after she was started on systemic multiple anti-androgen therapy for treatment of hirsutism.
Case report
A 24-year-old woman with a 4-month history of painless loss of vision and a diagnosis of CRVO in her left eye (OS) was referred for further evaluation and management. Her ocular history revealed squint surgery and amblyopia in her right eye (OD) since childhood. …
